(Also, fun fact about that prescribing physician in the post he actually has a larger role in the company as its chief medical officer.) And Musely doesnt mention any side effects on the creams product pages, simply stating in an FAQ on one of the product pages that, Your Musely board-certified dermatologist will guide you in a treatment plan regarding any skin concerns you may have. So, what are the potential side effects associated with these compounded products
In this guide, you will find: The dose ranges evaluated so far (112 mg weekly) How gradual titration influences outcomes and side-effect management Key distinctions between Retatrutide and other GLP-1/GIP agonists What upcoming data may suggest about its clinical and real-world potential Key Takeaways Retatrutide is an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors to improve metabolism and reduce appetite
References [1] Jastreboff, A
The effects on eating behaviors, reduced food preoccupation, and decreased binge urges make GLP-1s potentially very useful for binge eating disorder
Shipping without cold chain protocols